Onconetix (ONCO) Total Current Liabilities (2021 - 2026)
Onconetix (ONCO) posted quarterly Total Current Liabilities of $3.1 million for Q1 2026, down 78.16% year-over-year from $14.0 million in Q1 2025, and down 66.44% quarter-over-quarter from $9.1 million in Q4 2025.
Onconetix (ONCO) Total Current Liabilities (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Total Current Liabilities for 6 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 78.16% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 78.16% YoY), while the FY2025 annual figure was $9.1 million, down 50.05% from the prior year.
- Total Current Liabilities declined to $3.1 million in Q1 2026 per ONCO's latest filing, from $9.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $21.4 million in Q1 2024 and bottomed at $2.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $11.6 million across 5 years, with a median of $12.7 million in 2025.
- Annual changes were most pronounced in 2024 — Total Current Liabilities soared 663.14% — and 2026, when it sank 78.16%.
- Onconetix's Total Current Liabilities stood at $3.9 million in 2022, then jumped by 338.25% to $17.2 million in 2023, then rose by 6.4% to $18.3 million in 2024, then slumped by 50.05% to $9.1 million in 2025, then plunged by 66.44% to $3.1 million in 2026.
- Business Quant data shows ONCO's Total Current Liabilities at $3.1 million in Q1 2026, $9.1 million in Q4 2025, and $16.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | 3.07 Mn |
| Dec 31, 2025 | 9.14 Mn |
| Sep 30, 2025 | 16.30 Mn |
| Jun 30, 2025 | 12.69 Mn |
| Mar 31, 2025 | 14.04 Mn |
| Dec 31, 2024 | 18.29 Mn |
| Sep 30, 2024 | 17.36 Mn |
| Jun 30, 2024 | 20.60 Mn |
| Mar 31, 2024 | 21.43 Mn |
| Dec 31, 2023 | 17.19 Mn |
| Sep 30, 2023 | 17.65 Mn |
| Jun 30, 2023 | 12.13 Mn |
| Mar 31, 2023 | 2.81 Mn |
| Dec 31, 2022 | 3.92 Mn |
| Sep 30, 2022 | 4.43 Mn |
| Jun 30, 2022 | 3.06 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 1.64 Mn |